Pacgen Life Science Corp (PBS)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Pacgen Life Science Corp (PBS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013561
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pacgen Life Science Corp (Pacgen), formerly Pacgen Biopharmaceuticals Corp is a life science technology company that develops and commercializes biomedical products and services. The company offers development of novel therapeutic drug candidates. Its products include amino-acid antimicrobial peptide, oral healthcare, feminine care and home care products. It develops amino-acid antimicrobial peptide derived from a naturally occurring histatin protein found in human saliva for treatment of oral cavity, oral candidiasis and esophagus infection. The company’s oral healthcare products comprise anti- bacterial kid’s mouth spray, mouth-wash, and oral refreshers. It operates in Irvine, California, the US. Pacgen is headquartered in Vancouver, British Columbia, Canada.

Pacgen Life Science Corp (PBS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pacgen Life Science Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pacgen Life Science Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pacgen Life Science Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pacgen Life Science Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Pacgen Life Science Corp, Medical Devices Deals, 2011 to YTD 2017 9
Pacgen Life Science Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Pacgen Life Science Corp, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Pacgen Enters Into Licensing Agreement With General Biologicals For PAC-113 11
Pacgen BioPharma Amends Licensing Agreement With Demegen For PAC-113 12
Equity Offering 13
Pacgen Life Science Raises USD0.2 Million in Private Placement of Units 13
Pacgen Biopharma Completes Private Placement Of Shares For US$0.3 Million 14
Acquisition 15
Pacgen BioPharma To Acquire CurieMed 15
Pacgen Life Science Corp – Key Competitors 16
Pacgen Life Science Corp – Key Employees 17
Pacgen Life Science Corp – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Pacgen Life Science Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Pacgen Life Science Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pacgen Life Science Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pacgen Life Science Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pacgen Life Science Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Pacgen Life Science Corp, Medical Devices Deals, 2011 to YTD 2017 9
Pacgen Life Science Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Pacgen Enters Into Licensing Agreement With General Biologicals For PAC-113 11
Pacgen BioPharma Amends Licensing Agreement With Demegen For PAC-113 12
Pacgen Life Science Raises USD0.2 Million in Private Placement of Units 13
Pacgen Biopharma Completes Private Placement Of Shares For US$0.3 Million 14
Pacgen BioPharma To Acquire CurieMed 15
Pacgen Life Science Corp, Key Competitors 16
Pacgen Life Science Corp, Key Employees 17
Pacgen Life Science Corp, Subsidiaries 18

★海外企業調査レポート[Pacgen Life Science Corp (PBS)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Enbridge Energy Partners, L.P.:企業の戦略・SWOT・財務情報
    Enbridge Energy Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Enbridge Energy Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Tokio Marine Holdings, Inc.:企業の戦略・SWOT・財務情報
    Tokio Marine Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tokio Marine Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • BESIX Group SA:企業の戦略的SWOT分析
    BESIX Group SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Alternative Networks Plc:戦略・SWOT・企業財務分析
    Alternative Networks Plc - Strategy, SWOT and Corporate Finance Report Summary Alternative Networks Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Romelectro S.A.:企業の戦略的SWOT分析
    Romelectro S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Rex Energy Corp (REXX):石油・ガス:M&Aディール及び事業提携情報
    Summary Rex Energy Corp (Rex Energy) is an independent energy company. It carries out the acquisition, production, exploration and development of condensate, natural gas and natural gas liquids. It holds properties in Appalachian Basin. Rex Energy focuses on drilling and exploration activities in th …
  • Fauji Fertilizer Bin Qasim Limited (FFBL)-エネルギー分野:企業M&A・提携分析
    Summary Fauji Fertilizer Bin Qasim Limited (FFBL) is a chemical manufacturing company that manufactures, supplies and markets di ammonium phosphate (DAP) and granular urea. In addition, the company undertakes production and marketing of ammonia and other nitrogenous fertilizers for agricultural appl …
  • Hill-Rom Holdings, Inc.:戦略・SWOT・企業財務分析
    Hill-Rom Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hill-Rom Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Cpp Group Plc (CPP):企業の財務・戦略的SWOT分析
    Summary Cpp Group Plc (CPP), is a provider of bespoke products and solutions. It offers flight disruption insurance, legal protection, autocare, assetcare and mobile phone insurance. It offers services such as airport angel, card rescue, card protection, packaged accounts and travel assistance. CPP …
  • NovoCure Ltd (NVCR):企業の財務・戦略的SWOT分析
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …
  • Galapagos NV (GLPG):企業の財務・戦略的SWOT分析
    Summary Galapagos NV (Galapagos) is a biotechnology company that discovers and develops small molecule medicines for the treatment of inflammatory and fibrotic diseases. It offers Filgotinib medication targeting rheumatoid arthritis (RA). The company is investigating GLPG3667 compound against autoim …
  • ImpediMed Ltd (IPD):企業の財務・戦略的SWOT分析
    ImpediMed Ltd (IPD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Direct Energy Marketing Ltd:電力:M&Aディール及び事業提携情報
    Summary Direct Energy Marketing Ltd (Direct Energy), a subsidiary of Centrica plc, is a provider of energy and energy-related services. The company supplies, transports, and distributes natural gas and electricity. Direct Energy also installs and maintains heating, ventilation and air conditioning ( …
  • Samba Private Banking:企業の戦略・SWOT・財務分析
    Samba Private Banking - Strategy, SWOT and Corporate Finance Report Summary Samba Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Boralex Inc (BLX):企業の財務・戦略的SWOT分析
    Boralex Inc (BLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • JALUX Inc:企業の戦略・SWOT・財務情報
    JALUX Inc - Strategy, SWOT and Corporate Finance Report Summary JALUX Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Facebook, Inc.:戦略・SWOT・企業財務分析
    Facebook, Inc. - Strategy, SWOT and Corporate Finance Report Summary Facebook, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Aclara Technologies LLC:電力:M&Aディール及び事業提携情報
    Summary Aclara Technologies LLC (Aclara), a subsidiary of Hubbell Incorporated, is involved in designing, developing and commercializing Advanced Metering Infrastructure (AMI) solutions for data value management, customer communication and device networking activities. It provides an array of custom …
  • Metropolitan Bank and Trust Company:企業の戦略・SWOT・財務分析
    Metropolitan Bank and Trust Company - Strategy, SWOT and Corporate Finance Report Summary Metropolitan Bank and Trust Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Roche Diagnostics International Ltd-医療機器分野:企業M&A・提携分析
    Summary Roche Diagnostics International Ltd (Roche Diagnostics) offers novel diagnostic tests and systems for the early identification, targeted screening, assessment and monitoring of diseases. Its major products include point-of-care testing devices; analyzers, blood glucose meters; laboratory inf …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆